Global /United States /Healthcare /Biotechnology /UMEW

UMeWorld Inc.

UMEW

• OTCMKTS: UMEW • Delayed

0.5500USD 0%

As of 14 June 2026, UMeWorld Inc. has a market cap of $63.85M USD, ranking #28774 globally and #4291 in the United States. It ranks #2611 in the Healthcare sector, and #504 in the Biotechnology industry.

Global Rank

28774

Country Rank

4291

Sector Rank

2611

Industry Rank

504

Key Stats

Market Cap

$63.85MUSD

Enterprise Value

$63.79MUSD

Revenue (TTM)

$149.48KUSD

Net Income (TTM)

-$382.19KUSD

Profit Margin

-256%

PS Ratio

427.2

PB Ratio

-138.0

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Biotechnology

CEO

Michael M. Lee open_in_new

Employees

Founded

1997

Website

umeworld.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	0%	7.8%	38%	31%	53%	120%	293%	120%

News

Markets

Exchange	Ticker	Price	Quotes
OTC Markets (OTCMKTS / OTC) MIC: OTCM PRIMARY	UMEW ISIN: US90292A1051 Shares Out.: Shares Outstanding: 116.1M¹ Shares Float: 102.672M² TV: TradingView: OTC: UMEW SA: Stock Analysis: OTC: UMEW YF: Yahoo Finance: UMEW GF: Google Finance: OTCMKTS: UMEW BA: Barron's: UMEW MS: Morningstar: PINX: UMEW	0.5500 USD	TV: TradingView: OTC: UMEW SA: Stock Analysis: OTC: UMEW YF: Yahoo Finance: UMEW GF: Google Finance: OTCMKTS: UMEW BA: Barron's: UMEW MS: Morningstar: PINX: UMEW

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About UMeWorld Inc.

UMeWorld Inc., together with its subsidiaries, engages in the development and commercialization of functional nutrition and wellness products in the United States. It offers diacylglycerol-based cooking oils marketed under the DAGola brand and salad oil. The company was formerly known as UMeWorld Limited and changed its name to UMeWorld Inc. in October 2025. UMeWorld Inc. was incorporated in 1997 and is based in Miami, Florida. UMeWorld Inc. operates as a subsidiary of Vago International Limited.

Similar Companies

Industry: Biotechnology (United States)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 286K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 250K%	19.0	United States
Natera, Inc. NASDAQ: NTRA	$27.6B 43K%	-	United States
IQVIA Holdings Inc. NYSE: IQV	$26.3B 41K%	20.0	United States
United Therapeutics Corp. NASDAQ: UTHR	$25.03B 39K%	20.4	United States
Moderna, Inc. NASDAQ: MRNA	$18.13B 28K%	-	United States

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
argenx SE EBR: ARGX	$47.84B 41.39B EUR 75K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 70K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 66K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 66K%	37.2	Switzerland
Celltrion, Inc. KRX: 068270	$28.11B 42.76T KRW 44K%	43.8	South Korea
BioNTech SE NASDAQ: BNTX	$25.69B 40K%	-	Germany

chevron_leftBack